Montreal Heart Institute Developing Cardiac Screening Panel for GnuBio Sequencer | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — GnuBio said today that it is collaborating with the Montreal Heart Institute to develop a genetic panel that will run on the GnuBio platform and predict the risk of sudden cardiac death.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.